Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...
One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
News-Medical.Net on MSN
New trial aims to improve both survival and quality of life for men with advanced prostate cancer
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...
Although the use of tissue-based gene expression testing for prostate cancer was found to be “highly variable in the United States at the regional level,” distinct regional trajectories of commercial ...
MedPage Today on MSN
Kate Middleton's chemo; SGLT2 inhibitors and prostate cancer; new myeloma guidance
Kate Middleton, the Princess of Wales, opened up about her experience with chemotherapy during a visit to a London hospital. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results